National Jewish Health

National Jewish Health (previously National Jewish Medical and Research Center) is a research institute located in Denver, Colorado specializing in respiratory, immune and allergic research and treatment. It was founded in 1899 to treat tuberculosis, and is today considered one of the world's best medical research and treatment centers. It is a non-sectarian institution but received funding from B'nai B'rith until the 1950s. Today, clinical functions at National Jewish are limited to research, diagnosis, and ambulatory outpatient care. By the late 19th century, Colorado and the American Southwest had become famous for the health benefits of a dry, sunny climate. At that time, the only known treatment for tuberculosis (TB) was clean air and sunshine and hundreds of people with tuberculosis descended upon Denver in hopes of finding a miracle cure for what was then the nation’s leading cause of death. Consequently, many TB sufferers spent their last dollars coming to Colorado. By the 1890s, it was estimated that one out of every three residents of the state was there for respiratory reasons. However, no facilities existed to provide treatment or shelter to these victims.

Website
http://www.njc.org/index.aspx
Wikipedia
http://en.wikipedia.org/wiki/National_Jewish_Health

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Medical research

Compound in breast milk fights harmful bacteria

Researchers at National Jewish Health and the University of Iowa have identified a compound in human breast milk that fights infections by harmful bacteria while allowing beneficial bacteria to thrive. Human breast milk has ...

Immunology

Trigger for autoimmune disease identified

Researchers at National Jewish Health have identified a trigger for autoimmune diseases such as lupus, Crohn's disease and multiple sclerosis. The findings, published in the April 2017 issue of Journal of Clinical Investigation, ...

Health

Homeschooled kids sleep more than others

A new study published in Behavioral Sleep Medicine shows that children who are taught at home get more sleep than those who go to private and public schools. The findings provide additional evidence of teens' altered biological ...

Diabetes

Promising vaccine strategy for type 1 diabetes extended to humans

A molecule that prevents Type 1 diabetes in mice has provoked an immune response in human cells, according to researchers at National Jewish Health and the University of Colorado. The findings, published online in the Proceedings ...

Sleep apnea

After watching disturbing video, CPAP usage soars

Like more than 20 million other Americans, John Brugger has been diagnosed with sleep apnea. He snored, tossed and turned and struggled to breathe during the night, which often left him not only exhausted the next day but ...

Medical research

Vaccine adjuvant uses host DNA to boost pathogen recognition

Aluminum salts, or alum, have been injected into billions of people as an adjuvant to make vaccines more effective. No one knows, however, how they boost the immune response. In the March 19, 2013, issue of the Proceedings ...

Medications

Triple-combination therapy helps more people with cystic fibrosis

Researchers at National Jewish Health and around the world report today that a three-drug combination of medications can improve lung function, reduce exacerbations and improve quality of life for people with cystic fibrosis ...

Diseases, Conditions, Syndromes

Nintedanib slows progression for broad range of scarring lung diseases

Nintedanib, a medication approved for the treatment of idiopathic pulmonary fibrosis, slows the decline in lung function among patients with a broad range of scarring lung diseases. The findings, published in the New England ...

page 1 from 6